Quarterly Activities/Appendix 4C Cash Flow Report

• £2.2m (A$4.5m) positive Total Operating and Investing cash inflow in Q2-25
• 1.3% increase in Consultations QoQ
• Margin improvements continue in Q2 with further savings expected in H2-25

Doctor Care Anywhere Group Plc (ASX:DOC) reported a £2.2m (A$4.5m) positive Total Operating and Investing cash inflow in Q2 2025, a historic milestone in the company's financial performance. This compares to ~breakeven in the prior corresponding period and a £1.6m (A$3.3m) outflow in Q1 2025. The company saw a 1.3% increase in Consultations quarter-on-quarter, in line with management expectations. Growth initiatives are underway, such as the introduction of Physiotherapy and Mental Health services, as well as new contracts signed with Sante Group, Zest and Biffa. Margin improvements continued in Q2, reflecting cost base transformation and utilisation initiatives, with material further savings expected in H2 2025. The company exited the quarter with £4.8m (A$9.8m) in cash on the balance sheet. Key operational and financial matters include the broadening of clinician skill mix, simplification of the patient booking journey, and new client wins.

The company aims to double revenues in 3-5 years, from £38m (A$78m) in 2024, reflecting a 12-19% CAGR. The company's target underlying EBITDA margin is 15% at the end of this period.